Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies

被引：0
|
作者：
Laura Schwenk
Susan Wittig
Bernd Gruhn
机构：
[1] Jena University Hospital,Department of Pediatrics
来源：
Journal of Cancer Research and Clinical Oncology | 2022年 / 148卷
关键词：
Interleukin 10; Single nucleotide polymorphism; Allogeneic hematopoietic stem cell transplantation; Children; Relapse rate; Event-free survival;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：985 / 991
页数：6
相关论文
共 50 条
  • [1] Interleukin-10-592 polymorphism: impact on relapse and survival after allogeneic hematopoietic stem cell transplantation in children with hematological malignancies
    Schwenk, Laura
    Wittig, Susan
    Gruhn, Bernd
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2022, 148 (04) : 985 - 991
  • [2] Interleukin-10-592 CC genotype in the donor confers strong protection against relapse after allogeneic haematopoietic stem cell transplantation in children with haematological malignancies
    Gruhn, B.
    Voigt, J.
    Pfaffendorf-Regler, N.
    Wolff, I.
    Zintl, F.
    Beck, J. F.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S293 - S295
  • [3] IMPACT OF CHRONIC GVHD ON LATE RELAPSE, TREATMENT RELATED MORTALITY AND SURVIVAL AFTER ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    Boyiadzis, M.
    Klein, J. P.
    Arora, M.
    Weisdorf, D. J.
    Hassebroek, A.
    Lee, S. J.
    Flowers, M. E.
    Cutler, C. S.
    Urbano-Ispizua, A.
    Antin, J. H.
    Bolwell, B. J.
    Cahn, J-Y
    Cairo, M. S.
    Gale, R. P.
    Herzig, R. H.
    Isola, L. M.
    Jacobsohn, D. A.
    Jagasia, M. H.
    Klumpp, T. R.
    Petersdorf, E. W.
    Wingard, J. R.
    Horowitz, M. M.
    Pavletic, S. Z.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2012, 18 (02) : S209 - S210
  • [4] Allogeneic hematopoietic stem-cell transplantation for hematological malignancies
    Michallet, M
    Dhedin, N
    Michallet, AS
    BULLETIN DU CANCER, 2001, 88 (09) : 908 - 926
  • [5] The efficacy of the second allogeneic hematopoietic stem cell transplantation in children with refractory hematological malignancies
    Kozhokar, Polina
    Paina, Olesya
    Borovkova, Anastasia
    Frolova, Anastasia
    Semenova, Elena
    Osipova, Anna
    Bykova, Tatyana
    Ekushov, Kirill
    Slesarchuk, Olga
    Babenko, Elena
    Zubarovskaya, Ludmila
    Afanasyev, Boris
    BONE MARROW TRANSPLANTATION, 2018, 53 : 521 - 522
  • [6] Daratumumab and Venetoclax-Containing Regimens in the Management of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation in Hematological Malignancies
    Yang, Fan
    Li, Zhihui
    Dong, Changwei
    Lei, Yang
    Geng, YanPing
    Wen, XiaoPei
    Zhou, Yan
    Wu, Tong
    BLOOD, 2020, 136
  • [7] Outcomes of Children with Hematologic Malignancies Who Relapse After Allogeneic Hematopoietic Cell Transplantation
    Shah, Nirali N.
    Borowitz, Michael J.
    Robey, Nancy
    Gamper, Christopher
    Symons, Heather J.
    Loeb, David
    Wayne, Alan S.
    Chen, Allen R.
    BLOOD, 2012, 120 (21)
  • [8] THE IMPACT OF RESOLVED HEPATITIS B INFECTION ON ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HEMATOLOGICAL MALIGNANCIES
    Ramos, C. A.
    Saliba, R. M.
    Giralt, S.
    Khorshid, O.
    de Padua, L.
    Andersson, B. S.
    Nieto, Y. L.
    Popat, U. R.
    Qazilbash, M. H.
    Qureshi, S.
    Zhang, W.
    Champlin, R. E.
    de Lima, M.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2008, 14 (02) : 8 - 8
  • [9] Outcome of Children with Hematological Malignancies who Develop Mixed Donor Chimersim after Allogeneic Hematopoietic Stem Cell Transplantation
    Dotan, Amit
    Zevy, Danna
    Chiang, Kuang-Yueh
    Schechter-Finkelstein, Tal
    Ali, Muhammed
    Krueger, Joerg
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 535 - 536
  • [10] RELAPSE AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN HEMATOLOGICAL MALIGNANCIES: FACTORS IMPACTING ITS OCCURRENCE AND TREATMENT OPTIONS FOR A BETTER MANAGEMENT
    Michallet, M.
    Sobh, M.
    Morisset, S.
    Detrait, M.
    Labussiere, H.
    Ducastelle, S.
    Barraco, F.
    Chelghoum, Y.
    Thomas, X.
    Nicolini, F.
    HAEMATOLOGICA, 2012, 97 : 402 - 403
12345